Related Experiment Videos
Flavobacterium odoratum ventriculitis treated with intraventricular cefotaxime
The Journal of Infection
|November 1, 1985
Summary
Intraventricular cefotaxime effectively treated ventriculitis caused by Flavobacterium odoratum in an infant. This targeted therapy rapidly eliminated bacteria, leading to a sterile cerebrospinal fluid and successful patient recovery.
Area of Science:
- Pediatric Infectious Diseases
- Neurosurgery
- Clinical Microbiology
Background:
- Hydrocephalus in infants can lead to secondary infections like ventriculitis.
- Flavobacterium odoratum is a rare but serious pathogen causing central nervous system infections.
Observation:
- A 6-week-old infant developed ventriculitis with heavy Flavobacterium odoratum growth.
- Initial intravenous cefotaxime therapy was ineffective in clearing the infection.
Findings:
- Intraventricular cefotaxime administration via a Pudenz reservoir demonstrated high antibacterial activity.
- Rapid elimination of bacteria and sterile ventricular fluid were observed during and after treatment.
- The infant recovered without sequelae after shunt placement.
Implications:
- Intraventricular antibiotic therapy is a viable treatment option for resistant ventriculitis.
- Targeted intraventricular administration can overcome challenges in treating CNS infections.
- This case highlights successful management of a rare pathogen in infant hydrocephalus.